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Abstract 
Objectives: Survival in infants with gastroschisis is increasing although little is known about 
early childhood morbidity. In the context of a hypothesised link between the gastrointestinal (GI) 
tract and immune function, this study explores rates of GI and respiratory infections in children 
with gastroschisis. 
Methods: We conducted a population-based retrospective cohort study using data from the 
Health Improvement Network (THIN), a large database of UK primary care medical records. We 
identified children born from 1990 to 2013, and extracted follow-up data to their fifth birthday. 
We calculate incidence rates (IR) of GI and respiratory tract infections, overall and stratified by 
age, sex, socioeconomic status and gestational age at birth, and compared these between children 
with and without gastroschisis by calculating adjusted incidence rate ratios (aIRR).  
Results: Children with gastroschisis had a 65% higher IR of GI infection compared to children 
without (aIRR 1.65, 95% CI 1.37-1.99, p<0.001). Children with gastroschisis had a 27% higher 
IR of all respiratory tract infections (aIRR 1.27, 95% CI 1.12-1.44, p<0.001) and more than 2-
fold increase in lower respiratory tract infections compared to children without the condition 
(aIRR 2.15, 95% CI 1.69-2.74, p<0.001).  
Conclusions: Children born with gastroschisis have a significantly higher incidence of GI and 
respiratory tract infections compared to children without gastroschisis. This association requires 
further investigations but could be related to the neonatal care they receive such as delayed 
eneteral feeding or frequent antibiotic courses altering the gut microbiome and developing 
immune system. 
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What is known? 
• The short-term consequences of gastroschisis and persistence of longer-term functional 
gastrointestinal (GI) symptoms are well documented.  
• The GI tract is an integral component of the developing immune system.  
• Little is known about longer-term impacts of gastroschisis on immune function. 
What is new? 
• In early childhood, children with gastroschisis have higher incidence rates of GI and 
respiratory infections recorded in primary care than children without gastroschisis. 
• These findings persist even after adjusting for gestation at birth, sex and socioeconomic 
status. 
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Introduction 
Gastroschisis is a congenital defect of the anterior abdominal wall with an incidence of 1 in 
2,500 births[1] equating to approximately 300 babies per year in the United Kingdom (UK). 
Survival rates for infants with gastroschisis now exceed 95%, largely due to advances in neonatal 
care and surgical management[2]. 
Short-term neonatal complications of gastroschisis are well-documented[3]. After undergoing 
corrective surgery nearly all children require total parenteral nutrition (TPN), until the 
establishment of enteral feeds,  which brings attendant risks of catheter related sepsis[4]. These 
infants can remain in the neonatal unit for many weeks or months and often require multiple 
courses of antibiotics[5], potentially altering their gut microbial flora and long-term immune 
function[6]. 
Long-term outcomes in children with gastroschisis have focused on recurring abdominal pain or 
functional gastrointestinal (GI) symptoms, such as indigestion, chronic diarrhoea and 
constipation[7–13]. However, the majority of these studies are small, based on single centres, 
and many have pooled children born with gastroschisis with children born with omphalocele, 
despite their different embryological origins and clinical courses[7,10–13].  
Here we report results from a UK population-based cohort study comparing the incidence of 
recorded common childhood GI and respiratory infections in children with and without 
gastroschisis, from the point of registration with a general practitioner (GP) to their fifth 
birthday. 
 
Methods 
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Dataset and study population 
Data were derived from The Health Improvement Network (THIN) database of anonymised 
patient primary care records from UK general practices[14]. We used the version of THIN 
comprising data to January 2013 and including 11,764,660 patient records collected from 570 
UK practices. The THIN database is representative of the UK population in terms of patient age 
and sex, though slightly over represents patients from less socioeconomically deprived areas[15].  
All children in THIN who were born between January 1990 and January 2013 and registered 
with a GP within the first six months after birth were included in the study. Children with any 
major congenital anomaly (based on the European Surveillance of Congenital Anomalies 
definition[16]) other than gastroschisis were excluded. Children were followed up from the date 
they were registered with the GP until the day before their fifth birthday, or the date they died, 
transferred to another practice or the date of last data collection. 
Definitions of exposure and outcomes  
We used Read codes[17] (available on request) recorded in THIN to identify individuals with 
gastroschisis and the outcomes of interest. The exposed group was defined as children with 
gastroschisis and the non-exposed group comprised all other children.  
In line with previously-published work[18], our primary outcomes were episodes of GI infection 
and respiratory tract infection (RTI) diagnosed by a general practitioner. Children were defined 
as having a GI infection if they had at least one clinical diagnosis of a relevant infection (e.g. 
infectious colitis or gastroenteritis) or an infection-related symptom (e.g. vomiting or diarrhoea) 
recorded in their primary care records during the follow-up period. Symptom codes were 
included, in line with other work[19], as most cases of GI infection which present to a GP will 
not be confirmed by laboratory testing. The 15th day after the initial diagnosis of an infection 
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was defined as the date of recovery. If a subsequent diagnosis was recorded prior to the recovery 
date, this was considered to be part of the same infection episode and the recovery date was 
extended to the 8th day after this recording (only if later than the original recovery date), to 
ensure each episode lasted at least 14 days. Any additional recordings prior to the recovery date 
were treated similarly. Recordings after the date of recovery were treated as a new episode of 
illness. Similar procedures were used to identify and classify episodes of RTI if children had at 
least one recorded clinical diagnosis of RTI (e.g. common cold, tonsillitis, bronchitis) or an 
infection-related symptom (e.g. sore throat). 
Other co-variables  
Where available, data were also extracted on co-variables which were potentially associated with 
changes in infection rates. These included sex, socioeconomic status measured using Townsend 
quintile of deprivation, and gestational age at birth (classified as <32, 32-36, and 37+ completed 
weeks). Children’s follow-up time was split into five age groups: 0-1, 1-2, 2-3, 3-4 and 4-5 
years.  
Data analysis   
All data management and analyses were carried out using STATA v14 (Stata Corp, College 
Station, TX). The characteristics of children with and without gastroschisis were described, 
including sex, Townsend quintile of deprivation, gestational age at birth, age of child at start of 
follow-up and length of follow-up. Univariable analyses (chi-squared test, t-test or Wilcoxon 
rank sum test, as appropriate) were carried out to identify significant differences in the 
characteristics between children with and without gastroschisis. Missing data for Townsend 
quintile of deprivation and gestational age at birth were included in separate categories. 
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The number of episodes of GI and respiratory infection and the absolute rate per 10 person years 
with 95% confidence intervals (95% CIs) were calculated, both overall and separately for each 
co-variable for both children with and without gastroschisis. Absolute rate differences with 95% 
CIs comparing children with and without gastroschisis were calculated. Incidence rate ratios 
(IRRs) were calculated overall and separately for each co-variable using negative binomial 
regression with a logarithmic link function (as the assumptions of the Poisson distribution were 
not met, based on the Pearson’s goodness-of-fit statistic) with adjustment for co-variables.  
Sensitivity analysis 
We conducted two sensitivity analyses to minimise ascertainment bias and assess whether the 
incidence of more severe infection differed between groups. Symptomatic Read codes were 
included in the case definitions of GI infection described above, as GPs may use such codes 
alongside specific diagnostic codes for childhood infections in their routine practice. However, 
this approach could result in the inclusion of some non-infectious conditions. Therefore, we 
examined only the recording of specific GI infections, excluding symptomatic codes. We also 
examined the occurrence of lower respiratory tract infections (LRTI), i.e. influenza, pneumonia, 
bronchitis or bronchiolitis, excluding upper RTIs and symptom codes. The incidence rates of 
specific GI infection and LRTI were calculated and compared between children with and without 
gastroschisis.  
Our primary analyses used data from all children born from January 1990 onwards who 
registered with a GP within six months of birth. However, this is likely to have introduced some 
selection bias as sicker children who did not survive to discharge were excluded, a particular 
problem in the early years of the study period when mortality rates from gastroschisis were 
higher. To address this bias we conducted a sensitivity analysis calculating adjusted incidence 
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rate ratios for all GI and respiratory infections in a subset of children born from January 2000 
only. 
Ethical approval 
The providers of the THIN data received ethical approval for the collection of data from GP 
practices from the South East Multicentre Research Ethics Committee (SE-MREC). Individual 
studies using THIN data do not require further separate ethical approval if only anonymised 
THIN data are used. The protocol for this project was approved by the THIN Scientific Review 
Committee (reference 15THIN066). 
 
Results 
The study cohort consisted of 942,810 children who met the inclusion criteria, 212 with 
gastroschisis and 942,598 without (an incidence of 0.56 cases per 2,500 children included). The 
median duration of follow-up in the dataset was 4.8 years (interquartile range 2.0-4.9 years) and 
52.9% of children had data to the age of five. There were no significant differences between the 
sexes of the children in the two groups, though children with gastroschisis were more likely to be 
from more deprived areas and to have been born prematurely (Table 1).  
GI infections  
The overall incidence rate of GI infection per 10 person years (hereafter referred to as incidence 
rate) in children born with gastroschisis was 2.64 per 10 person years (95% CI 2.27-3.06), higher 
than the rate of 1.61 (95% CI 1.61-1.62) in children without gastroschisis (Table 2). The 
unadjusted IRR was marginally attenuated after adjustment for age, sex, socioeconomic status 
and gestational age at birth (adjusted IRR 1.65, 95% CI 1.37-1.99, p<0.001). GI infection rates 
10 
were generally higher in children born with gastroschisis compared to children without across all 
categories of co-variables (Table 2).  
Respiratory infections 
The overall incidence rate of RTI in children born with gastroschisis was 7.94 (95% CI 7.28-
8.67), higher than the rate of 6.11 (95% CI 6.10-6.12) observed in children born without 
gastroschisis (Table 3). The unadjusted rate ratio was only marginally attenuated after 
adjustment for age, sex, socioeconomic status and gestational age at birth (adjusted IRR 1.27, 
95% CI 1.12-1.44, p<0.001).  
After adjusting for other variables, incidence rates increased in children with gastroschisis of 
both sexes and in all age groups (though only reached statistical significance in the 1-2 years age 
group). Rates were also higher in children with gastroschisis than children without gastroschisis 
in all deprivation groups (Table 3). Comparison of incidence by gestational age was limited by 
the small number of infection episodes in children born at <32 completed weeks’ gestation, 
though for children born at term there was some evidence of an increased rate of RTI in children 
with gastroschisis compared to those without, though the effect estimate was marginally non-
significant.  
Sensitivity analyses 
After excluding GI infections identified using symptomatic Read codes, there were very few 
episodes of GI infection in children born with gastroschisis (11 events), which precluded 
assessment of rates by subgroup. The overall adjusted IRR of GI infection was not statistically 
significant (adjusted IRR 0.69, 95% CI 0.38-1.25, p=0.218). 
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Overall the number of LRTI episodes were lower than RTI episodes (Table 4). The rate of LRTI 
was higher in children with gastroschisis than children without and the adjusted IRR was 2.15 
(95% CI 1.69-2.74, p<0.001) which was higher than that for RTI. The pattern in the IRRs across 
categories of age, sex, socioeconomic status and gestational age at birth were broadly similar for 
LRTIs compared to RTIs, though generally the magnitude of the effect estimates were higher 
(Table 4).  
The incidence of gastroschisis in the subset of children born from January 2000 onwards was 
0.71 cases per 2,500 registered children. Overall adjusted IRRs for the primary outcomes were 
similar in the subset of children born from 2000 onwards compared to the full dataset (adjusted 
IRR for GI infection 1.46, 95% CI 1.19-1.78, p<0.001; adjusted IRR for RTI 1.23, 95% CI 1.08-
1.40, p=0.002). 
 
Discussion 
To our knowledge, this is the largest population-based cohort study of children with 
gastroschisis. We identify significantly higher incidence rates of GI and respiratory infections in 
children born with gastroschisis, compared to children without, over the first five years of life 
following hospital discharge after birth. Particularly, we found a 2-fold increased incidence rate 
of LRTIs in children with gastroschisis, as diagnosed by their general practitioner, compared to 
children without, after adjusting for age, sex, socioeconomic status and gestational age at birth. 
Previous studies have noted a relatively high number of babies with gastroschisis admitted to 
neonatal intensive care units developed viral respiratory tract infections [20,21]. However, none 
of these studies have been able to examine the risk of common infections after children are 
discharged from the hospital. Our findings from this exploratory study support the hypothesis 
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that children with gastroschisis may have a dysfunctional immune system and so be more likely 
to develop GI and respiratory infections in early life.  
The GI tract is an integral component of the immune system[22]. In gastroschisis, however, GI 
tract development is altered both pre- and postnatally. The gut flora plays an important part in 
immune function[23] and there is a bi-directional relationship between GI motility and 
microbiota[24]. The colonisation of the GI tract in infants born with gastroschisis may be 
affected by delay in establishing enteral feeds and administration of antibiotics  to prevent and 
treat sepsis, which may also affect the healthy balance of bacteria[6,25,26]. Infants with 
gastroschisis may also have dysmotility which has also been found to lead to overgrowth of 
bacteria in short bowel[24]. Alterations to the gut flora may have long-term immunological 
consequences. Indeed, as well as reports of increased susceptibility to viral respiratory tract 
infection[20,21], gastroschisis is associated with immune dysfunction including cow’s milk 
protein allergy[27], hypogammaglobulinaemia[28], and secondary non-severe combined 
immunodeficiency (SCID) T-cell lymphopenia[29].  
Our findings persist after adjustment for gestational age at birth, suggesting an association 
independent of the effect of the reduced immune function which has been shown to persist in 
preterm children in later life[30]. Similarly, our results also remain after adjustment for 
socioeconomic status, a variable which helps to account for any differences in healthcare seeking 
behaviour related to parental affluence.  
A key strength of this work is the relatively large number of children with gastroschisis studied. 
Compared to the use of bespoke surveys, primary care data afford the opportunity to follow up 
substantial numbers of children with rare conditions with relative ease. Additionally, the data 
were nationally representative with a similar age and sex distribution to the general population in 
the UK[15]. The use of data recorded during the course of routine primary care practice reduces 
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the potential for recall bias, a limitation of some previous studies[8,9]. The large dataset also 
enabled analyses to be stratified by and adjusted for socio-demographic characteristics and 
gestational age at birth. However, power was limited in some subgroups, and by the absence of 
data on other important potential confounders such as birth weight and exposure to tobacco 
smoke during gestation and childhood which are incompletely recorded in THIN.  
We identified children with gastroschisis based on clinical diagnosis recorded in primary care. 
The incidence of gastroschisis recorded in THIN, using a denominator of children registered 
with a GP, was however lower than the incidence among live births suggested by recent national 
registry data[1]. The present study only includes children who survived to discharge from 
hospital. With both the increase in incidence and better survival rates in recent years[5], it is 
probable the lower incidence in this study is a reflection of this. Indeed, our study data show 
increases in incidence from approximately the year 2000 onwards; the confidence interval for the 
incidence rate spans the value of 1 per 2,500 included children for nine of the years from 2000 
onwards, compared to none beforehand. Our sensitivity analysis showed similar incidence rate 
ratios for GI and respiratory infection in the subset of children born from 2000 onwards 
compared to the full dataset, suggesting a minimal impact of selection bias on our primary 
results. The THIN database does marginally underrepresent more deprived areas of the UK[15], 
and as gastroschisis is associated with deprivation it may therefore miss some cases.  
Our definitions of episodes of infection were necessarily broad, based on recorded diagnostic 
and symptom codes by the child’s general practitioner. With the data available to us it was not 
possible to identify, for example, GI upset due to underlying disease (such as a persistent ileus) 
as opposed to infection. Less severe infections may not be recorded in primary care if a parent 
feels they do not warrant consultation with a GP, and conversely, more severe infections treated 
directly in hospital may also not be fully transcribed into GP records. A GP’s propensity to 
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investigate a potential infection further, perhaps requesting microbiology tests, may be 
influenced by the presence of any underlying health conditions in a child, though this 
ascertainment bias may not apply with more severe infections. Our sensitivity analysis 
demonstrated increased LRTI rates in children with gastroschisis compared to children without 
gastroschisis, which helps to exclude the possibility of ascertainment bias affecting the primary 
analysis. In addition, based on our algorithm a child with gastroschisis reporting bowel 
dysfunction such as chronic diarrhoea may have been miscoded as having GI infection which 
could result in a higher recorded rate of GI infection in our study. Whilst this may also occur in 
the non-gastroschisis group, the misclassification is likely to be differential as studies have 
consistently identified GI tract dysfunction as an issue in gastroschisis[8,9,31]. Our sensitivity 
analysis excluding recordings of GI symptoms found a decreased GI infection rate in children 
with gastroschisis compared to children without. However, this result was not statistically 
significant and was based on only 11 infection episodes in children with gastroschisis; we 
therefore cannot rule out the potential for elevated GI infection rates in children with 
gastroschisis.  
Future work could usefully consider differences between groups in treatment for infections, such 
as antibiotic prescribing, or investigate hospital admissions using linked secondary care data. 
This would help identify the most severe infections, but would exclude less severe, but more 
common, infections where a GP may recommend supportive care only. In addition, further work 
would be helpful to explore the impact of other potential confounders and effect modifiers, 
particularly where good quality data are only available from linked secondary care records; this 
could include the effects of maternal age and parity, more complete data on gestational age, 
birthweight, presence of other congenital anomalies, complexity of gastroschisis and frequency 
of consultation with a GP.  
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The absolute difference in the incidence of infection between children with and without 
gastroschisis is relatively small. However, understanding the later outcomes of gastroschisis is 
important to the growing number of survivors and their caregivers, and longer-term follow-up to 
assess whether increased infection rates persist would be useful. The results of this study could 
help to inform further research and prevention strategies and to ensure appropriate preventive 
and management advice is given to reduce the burden of infection. For example, if there is 
indeed an immune component at play, promotion of smoking cessation, improving breastfeeding 
rates and early use of probiotics[32] may be beneficial to provide extra immune protection or a 
more natural gut microbiota and potentially reduce infection incidence in children with 
gastroschisis. 
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interest 
Table 1 
(c) Summarise follow-up time (eg, average and total amount) 8, Table 1 
Outcome data 15* Report numbers of outcome events or summary measures over time Table 2,3 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted 
estimates and their precision (eg, 95% confidence interval). Make clear 
which confounders were adjusted for and why they were included 
8,9, Table 
2,3 
(b) Report category boundaries when continuous variables were 
categorized 
N/A 
(c) If relevant, consider translating estimates of relative risk into absolute 
risk for a meaningful time period 
N/A 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, 
and sensitivity analyses 
9,10, Table 
4 
 Discussion  
Key results 18 Summarise key results with reference to study objectives 10 
Limitations 19 Discuss limitations of the study, taking into account sources of potential 
bias or imprecision. Discuss both direction and magnitude of any potential 
bias 
11,12 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, 
limitations, multiplicity of analyses, results from similar studies, and other 
relevant evidence 
10-13 
Generalisability 21 Discuss the generalisability (external validity) of the study results 10 
Other information  
Funding 22 Give the source of funding and the role of the funders for the present 
study and, if applicable, for the original study on which the present article 
is based 
1 
*Give information separately for exposed and unexposed groups. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background 
and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article 
(freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine 
at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is 
available at http://www.strobe-statement.org. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 1: Characteristics of children with and without gastroschisis   
  Children with 
gastroschisis 
n (%) 
Children without 
gastroschisis 
n (%) 
p-value for 
difference 
Total  212 (0.02) 942,598 (99.98)  
Sex 
Female 107 (50.5) 459,141 (48.7) 0.608 
Male 105 (49.5) 483,457 (51.3) 
Townsend deprivation quintile 
1 (least deprived) 23 (10.9) 202,499 (21.5) <0.001 
2 25 (11.8) 173,584 (18.4) 
3 42 (19.8) 184,802 (19.6) 
4 52 (24.5) 175,950 (18.7) 
5 (most deprived) 53 (25.0) 133,131 (14.1) 
Missing  17 (8.0) 72,632 (7.7) 
Gestational age at birth (completed weeks) 
37+ 105 (49.5) 649,575 (68.9) <0.001 
32-36 42 (19.8) 35,464 (3.8) 
<32 4 (1.89) 6,456 (0.68) 
Missing 61 (28.8) 251,103 (26.6) 
Age of child at start of follow-up (days) 
Median (IQR) 43.5 (30.0-60.0) 30.0 (15.0-43.0) <0.001 
Length of follow-up (months) 
Median (IQR) 42.9 (15.7-59.1) 58.4 (24.3-59.8) <0.001 
IQR=interquartile range
 Table 2: Incidence rates and rate ratios of gastrointestinal tract infection in children with and without gastroschisis 
 Children with gastroschisis Children without gastroschisis     
 Events Rate per 10 person 
years (95% CI) 
Events  Rate per 10 person 
years (95% CI) 
Rate difference (95% 
CI) 
Unadjusted IRR 
(95% CI) p-value 
Adjusted IRR# (95% 
CI) p-value  
Overall 171 2.64 (2.27-3.06) 538386 1.61 (1.61-1.62) 1.03 (0.63-1.42) 1.64 (1.40-1.90) <0.001 1.65 (1.37-1.99) <0.001 
Age (years)         
0-1 68 4.14 (3.26-5.25) 232772 2.93 (2.92-2.94) 1.20 (0.22-2.19) 1.41 (1.12-1.78) 0.004 1.37 (1.06-1.75) 0.014 
1-2 51 3.26 (2.48-4.29) 159612 2.10 (2.09-2.11) 1.17 (0.27-2.06) 1.56 (1.16-2.05) 0.002 1.78 (1.11-2.75) 0.009 
2-3 30 2.30 (1.61-3.29) 74834 1.12 (1.11-1.13) 1.18 (0.36-2.00) 2.05 (1.38-2.93) <0.001 2.41 (1.39-4.19) 0.002 
3-4 19 1.75 (1.12-2.74) 42422 0.72 (0.71-0.72) 1.03 (0.24-1.82) 2.44 (1.47-3.81) <0.001 3.00 (1.51-5.96) 0.002 
4-5 3 0.34 (0.11-1.05) 28746 0.55 (0.54-0.55) -0.21 (-0.59-0.18) 0.62 (0.13-1.81) 0.213 0.53 (0.15-1.86) 0.324 
Sex          
Female 82 2.44 (1.97-3.03) 250741 1.54 (1.54-1.55) 0.90 (0.37-1.43) 1.58 (1.26-1.97) <0.001 1.57 (1.20-2.04) 0.001 
Male 89 2.85 (2.32-3.51) 287645 1.68 (1.67-1.69) 1.17 (0.58-1.76) 1.70 (1.36-2.09) <0.001 1.74 (1.34-2.25) <0.001 
Townsend deprivation quintile        
1 (least deprived) 22 2.82 (1.86-4.29) 116910 1.50 (1.49-1.51) 1.32 (0.14-2.50) 1.88 (1.18-2.85) 0.003 1.80 (1.11-2.93) 0.017 
2 31 3.87 (2.72-5.50) 95943 1.49 (1.48-1.50) 2.38 (1.02-3.74) 2.60 (1.76-3.68) <0.001 2.86 (1.84-4.46) <0.001 
3 29 2.20 (1.53-3.16) 103527 1.58 (1.57-1.59) 0.61 (-0.19-1.41) 1.39 (0.93-1.99) 0.045 1.39 (0.90-2.15) 0.136 
4 33 2.09 (1.49-2.95) 102061 1.70 (1.69-1.71) 0.40 (-0.32-1.11) 1.23 (0.85-1.73) 0.117 1.30 (0.85-1.99) 0.220 
5 (most deprived) 40 2.55 (1.87-3.47) 82933 1.88 (1.87-1.90) 0.67 (-0.12-1.46) 1.35 (0.97-1.84) 0.033 1.48 (0.99-2.21) 0.056 
Missing 16 3.66 (2.24-5.98) 37012 1.67 (1.65-1.69) 1.99 (0.20-3.79) 2.19 (1.25-3.56) 0.003 2.05 (1.09-3.86) 0.026 
Gestational age at birth (complete weeks)        
37+ 83 2.59 (2.08-3.21) 423247 1.83 (1.82-1.84) 0.76 (0.20-1.31) 1.41 (1.13-1.75) 0.001 1.36 (1.05-1.76) 0.018 
32-36 42 3.02 (2.23-4.09) 25939 2.13 (2.11-2.16) 0.89 (-0.02-1.81) 1.42 (1.02-1.92) 0.015 1.60 (1.08-2.37) 0.018 
<32 9 6.07 (3.16-11.67) 4766 2.13 (2.07-2.19) 3.94 (-0.03-7.90) 2.85 (1.30-5.41) 0.004 3.82 (1.43-10.21) 0.008 
Missing 37 2.13 (1.54-2.94) 84434 0.96 (0.95-0.96) 1.17 (0.49-1.86) 2.23 (1.57-3.07) <0.001 2.78 (1.75-4.42) <0.001 
# Adjusted for age, sex, Townsend deprivation quintile and gestational age at birth; CI=confidence interval; IRR=incidence rate ratio 
 
 
 
 
 
 
 Table 3: Incidence rates and rate ratios of respiratory tract infection in children with and without gastroschisis 
 Children with gastroschisis Children without gastroschisis     
 Events Rate per 10 person 
years (95% CI) 
Events  Rate per 10 person 
years (95% CI) 
Rate difference (95% 
CI) 
Unadjusted IRR 
(95% CI) p-value 
Adjusted IRR# (95% 
CI) p-value 
Overall 504 7.94 (7.28-8.67) 2003284 6.11 (6.10-6.12) 1.83 (1.14-2.53) 1.30 (1.19-1.42) <0.001 1.27 (1.12-1.44) <0.001 
Age (years)         
0-1 177 11.06 (9.55-12.82) 702290 9.07 (9.05-9.09) 1.99 (0.35-3.62) 1.22 (1.05-1.41) 0.005 1.18 (0.98-1.43) 0.086 
1-2 145 9.51 (8.09-11.20) 523199 7.01 (6.99-7.03) 2.50 (0.95-4.05) 1.36 (1.15-1.60)      <0.001 1.48 (1.15-1.92) 0.003 
2-3 77 6.00 (4.80-7.50) 326150 4.96 (4.94-4.98) 1.04 (-0.30-2.38) 1.21 (0.95-1.51) 0.051 1.20 (0.86-1.68) 0.292 
3-4 65 6.08 (4.77-7.76) 259172 4.45 (4.43-4.47) 1.63 (0.15-3.11) 1.37 (1.05-1.74) 0.008 1.33 (0.92-1.93) 0.133 
4-5 40 4.60 (3.37-6.27) 192473 3.71 (3.69-7.23) 0.89 (-0.54-2.32) 1.24 (0.89-1.69) 0.091 1.19 (0.75-1.90) 0.458 
Sex          
Female 260 7.91 (7.00-8.93) 931444 5.83 (5.82-5.84) 2.08 (1.12-3.04) 1.36 (1.20-1.53) <0.001 1.33 (1.12-1.59) 0.001 
Male 244 7.98 (7.04-9.05) 1071840 6.38 (6.37-6.39) 1.60 (0.60-2.60) 1.25 (1.10-1.42) <0.001 1.20 (1.01-1.43) 0.042 
Townsend deprivation quintile        
1 (least deprived) 52 6.78 (5.16-8.89) 448714 5.87 (5.85-5.89) 0.91 (-0.93-2.75) 1.15 (0.86-1.51) 0.150 1.08 (0.75-1.58) 0.671 
2 81 10.38 (8.35-12.90) 362645 5.73 (5.71-5.75) 4.65 (2.39-6.91) 1.81 (1.44-2.25) <0.001 1.84 (1.34-2.52) <0.001 
3 89 6.87 (5.58-8.46) 384703 5.99 (5.97-6.01) 0.88 (-0.55-2.30) 1.15 (0.92-1.41) 0.101 1.17 (0.88-1.57) 0.285 
4 105 6.72 (5.55-8.15) 374861 6.36 (6.34-6.38) 0.37 (-0.92-1.66) 1.06 (0.86-1.28) 0.280 1.06 (0.81-1.39) 0.653 
5 (most deprived) 145 9.51 (8.08-11.19) 301916 7.00 (6.98-7.03) 2.51 (0.96-4.05) 1.36 (1.15-1.60) <0.001 1.35 (1.06-1.71) 0.013 
Missing 33 7.68 (5.46-10.80) 130445 5.99 (5.96-6.02) 1.69 (-0.93-4.31) 1.28 (0.88-1.80) 0.082 1.24 (0.76-2.01) 0.386 
Gestational age at birth (complete weeks)        
37+ 260 8.29 (7.34-9.36) 1561444 6.89 (6.88-6.90) 1.39 (0.39-2.40) 1.20 (1.06-1.36) 0.002 1.18 (1.00-1.40) 0.053 
32-36 129 9.54 (8.03-11.33) 95587 8.05 (8.00-8.10) 1.49 (-0.16-3.13) 1.18 (0.99-1.41) 0.030 1.22 (0.96-1.56) 0.102 
<32 9 6.05 (3.15-11.63) 19266 8.87 (8.74-8.99)  -2.81 (-6.77-1.14) 0.68 (0.31-1.30) 0.123 0.60 (0.26-1.38) 0.229 
Missing 106 6.21 (5.14-7.52) 326987 3.75 (3.74-3.76) 2.47 (1.28-3.65) 1.66 (1.36-2.01) <0.001 1.62 (1.19-2.22) 0.003 
# Adjusted for age, sex, Townsend deprivation quintile and gestational age at birth; CI=confidence interval; IRR=incidence rate ratio 
 
 Table 4: Incidence rates and rate ratios of lower respiratory tract infection in children with and without gastroschisis (sensitivity analysis) 
 Children with gastroschisis Children without gastroschisis     
 Events Rate per 10 person 
years (95% CI) 
Events  Rate per 10 person 
years (95% CI) 
Rate difference (95% 
CI) 
Unadjusted IRR 
(95% CI) p-value  
Adjusted IRR# (95% 
CI) p-value  
Overall 135 2.08 (1.75-2.46) 350349 1.05 (1.04-1.05) 1.03 (0.71-1.41) 1.98 (1.68-2.35) <0.001 2.15 (1.69-2.74) <0.001 
Age (years)         
0-1 58 3.52 (2.72-4.55) 136525 1.71 (1.70-1.72) 1.81 (0.90-2.71) 2.05 (1.56-2.66) <0.001 2.18 (1.57-3.04) <0.001 
1-2 34 2.17 (1.55-3.03) 94044 1.23 (1.22-1.24) 0.93 (0.21-1.66) 1.76 (1.22-2.46) 0.001 1.96 (1.09-3.52) 0.024 
2-3 22 1.68 (1.11-2.56) 54530 0.82 (0.81-0.82) 0.87 (0.16-1.57) 2.06 (1.29-3.12) 0.001 2.77 (1.35-5.71) 0.006 
3-4 16 1.47 (0.90-2.40) 39078 0.66 (0.65-0.67) 0.81 (0.09-1.53) 2.23 (1.27-3.61) 0.002 2.58 (1.14-5.80) 0.022 
4-5 5 0.57 (0.24-1.36) 26172 0.50 (0.49-0.50) 0.07 (-0.43-0.56) 1.14 (0.37-2.65) 0.365 1.06 (0.33-3.42) 0.923 
Sex          
Female 60 1.78 (1.38-2.29) 153201 0.94 (0.93-0.94) 0.84 (0.39-1.29) 1.90 (1.45-2.44) <0.001 1.95 (1.36-2.79) <0.001 
Male 75 2.40 (1.91-3.00) 197148 1.15 (1.14-1.15) 1.25 (0.71-1.79) 2.09 (1.64-2.62) <0.001 2.34 (1.68-3.26) <0.001 
Townsend deprivation quintile        
1 (least deprived) 17 2.18 (1.35-3.50) 78660 1.01 (1.00-1.02) 1.27 (0.13-2.20) 2.16 (1.26-3.45) 0.002 1.91 (0.98-3.74) 0.059 
2 23 2.86 (1.90-4.30) 63384 0.98 (0.97-0.99) 1.87 (0.71-3.04) 2.91 (1.84-4.37) <0.001 3.03 (1.63-5.64) <0.001 
3 26 1.97 (1.34-2.89) 66273 1.01 (1.00-1.02) 0.96 (0.20-1.71) 1.94 (1.27-2.85) 0.001 2.35 (1.35-4.09) 0.003 
4 30 1.90-1.33-2.72) 65528 1.09 (1.08-1.10) 0.82 (0.13-1.50) 1.75 (1.18-2.50) 0.002 2.15 (1.29-3.59) 0.003 
5 (most deprived) 27 1.71 (1.18-2.50) 50962 1.15 (1.14-1.16) 0.56 (-0.09-1.21) 1.49 (0.98-2.16) 0.025 1.53 (0.91-2.59) 0.109 
Missing 12 2.74 (1.55-4.82) 25542 1.15 (1.14-1.16) 1.59 (0.04-3.14) 2.38 (1.23-4.16) 0.004 2.88 (1.18-7.02) 0.020 
Gestational age at birth (complete weeks)        
37+ 74 2.30 (1.83-2.89) 268125 1.16 (1.15-1.16) 1.15 (0.62-1.67) 1.99 (1.56-2.50) <0.001 2.51 (1.80-3.50) <0.001 
32-36 27 1.94 (1.33-2.82) 18476 1.51 (1.49-1.54) 0.42 (-0.31-1.15) 1.28 (0.84-1.86) 0.105 1.11 (0.68-1.84) 0.670 
<32 3 1.98 (0.64-6.15) 4268 1.91 (1.85-1.97) 0.08 (-2.17-2.32) 1.04 (0.21-3.04) 0.439 0.98 (0.21-4.70) 0.984 
Missing 31 1.78 (1.25-2.54) 59480 0.67 (0.67-0.68) 1.11 (0.48-1.74) 2.65 (1.80-3.76) <0.001 3.30 (1.86-5.88) <0.001 
# Adjusted for age, sex, Townsend deprivation quintile and gestational age at birth; CI=confidence interval; IRR=incidence rate ratio 
 
 
 
 
 
 
